Breaking News

INTERPHEX Names Industry Vice President

August 13, 2014

Palermo assumes strategic leadership role

RJ Palermo has been appointed industry vice president of INTERPHEX, responsible for all levels of event management and technical education. He will also continue to foster strategic relationships with pharma and biopharma industry leaders and associations to support industry initiatives. INTERPHEX, sponsored by Parenteral Drug Association (PDA), is an annual industry event dedicated to showcasing pharma and biopharma innovation, technology and knowledge.
Mr. Palermo has more than 20 years of industry contributions and leadership experience within the pharma and biopharma industries, and is an active member of the Parenteral Drug Association (PDA). He is currently a Trustee on the Health Science Industry Scholarship Fund dedicated to driving the next generation of pharmaceutical technical professionals.
"RJ is a proven leader with a passion for excellence and a deep understanding of our biopharmaceutical and pharmaceutical industries," said Ed Several, senior vice president, INTERPHEX Global. "Over the years, RJ has been a major contributor in building awareness, creating relevant technical educational programs and promoting success within the organization and, more important, INTERPHEX Global events. I look forward to his continued contributions in helping to utilize INTERPHEX as a platform for this great industry to achieve its goals.”

"I am honored to assume the industry leadership role of the INTERPHEX Global portfolio and remain committed to the innovation and excellence of the biopharmaceutical and pharmaceutical industries," said Mr. Palermo. "Along with my team of professionals, I am confident that we will continue to deliver the same level of commitment and dedication to the industries that we serve."

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks